Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications

Forms and Documents

Forms and supporting documents for this ICR

Document	Type	Status	Availability
0910-0810 change request 12.21.docx	Justification for No Material/Nonsubstantive Change	Uploaded 2021-12-14	Repair queued
Generic Clearance SS A_0820 2021 Final.pdf	Supporting Statement A	Uploaded 2021-09-16	Repair queued
GenericClearanceSSB_08102021Final.pdf	Supporting Statement B	Uploaded 2021-08-19	Repair queued
QualitativeandQuantitativeResearchonTobaccoProductsandCommunications342019.pdf	Supplementary Document	Uploaded 2021-08-11	Missing upstream
0810SummariesofGenericSubmissions2021.docx	Supplementary Document	Uploaded 2021-08-11	Available

IC Document Collections

Information collection document groups

IC ID	Collection	Type	Status	Form
251913	Nicotine Education Project	Other-Young Adult Consent Form	New

ICR Details

OMB Control No: 0910-0810	ICR Reference No: 202112-0910-006
Status: Received in OIRA	Previous ICR Reference No: 202108-0910-004
Agency/Subagency: HHS/FDA	Agency Tracking No: CTP
Title: Generic Clearance for the Collection of Quantitative Data on Tobacco Products and Communications
Type of Information Collection: No material or nonsubstantive change to a currently approved collection	Common Form ICR:  No
Type of Review Request: Regular	Date Submitted to OIRA: 12/14/2021

table that charts list comparision

	Requested	Previously Approved
Expiration Date	12/31/2024	12/31/2024
Responses	661,308	619,308
Time Burden (Hours)	91,865	85,041
Cost Burden (Dollars)	0	0

---

Abstract: The Food and Drug Administration (FDA) is requesting extension of approval of a generic for collecting information through the use of quantitative methods for studies about tobacco products. FDA will need to employ quantitative research, including surveys and experimental studies to assess knowledge and perceptions about tobacco-related topics with specific target audiences. FDA will only submit an individual generic collection for approval under this generic clearance if the individual collection meets the outlined conditions.

---

Authorizing Statute(s): PL: Pub.L. 111 - 111 31 Name of Law: Family Smoking Prevention and Tobacco Control Act
   US Code: 21 USC 372 Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 21 USC 393(d)(2)(D) Name of Law: Federal Food, Drug, and Cosmetic Act
   US Code: 42 USC 241(a) Name of Law: Public Health Service Act
   US Code: 21 USC 355 Name of Law: Federal Food, Drug, and Cosmetic Act
  

Citations for New Statutory Requirements: None

---

Associated Rulemaking Information
RIN:	Stage of Rulemaking:	Federal Register Citation:	Date:
	Not associated with rulemaking

---

Federal Register Notices & Comments
60-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 12952	03/05/2021
30-day Notice:	Federal Register Citation:	Citation Date:
	86 FR 51897	09/17/2021
Did the Agency receive public comments on this ICR? Yes

---

Number of Information Collection (IC) in this ICR: 0

---

ICR Summary of Burden

table that charts list of burden

	Total Request	Previously Approved	Change Due to New Statute	Change Due to Agency Discretion	Change Due to Adjustment in Estimate	Change Due to Potential Violation of the PRA
Annual Number of Responses	661,308	619,308	0	42,000	0	0
Annual Time Burden (Hours)	91,865	85,041	0	6,824	0	0
Annual Cost Burden (Dollars)	0	0	0	0	0	0

Burden increases because of Program Change due to Agency Discretion: Yes

Burden Increase Due to: Miscellaneous Actions

Burden decreases because of Program Change due to Agency Discretion: No

Burden Reduction Due to:

Short Statement: The Food and Drug Administration is submitting this non-substantive change request to add a second year of data collection to the individual generic approval “Monthly Monitoring Study” (ICR Reference 201907-0910-006). The purpose of the Monthly Monitoring Study is to assess changes in vape use and perceptions. Given the evolving tobacco product landscape resulting from changes in product regulations, e-cigarette brand and flavor availability, and the COVID-19 pandemic which has impacted youth vaping, we would like to extend our data collection for another year to continue to track how these factors impact youth’s use and perceptions around vaping in order to inform future communication and educational initiatives. We estimate the burden to be identical for the second year to the first year. Therefore, we are doubling the previous estimate to cover the second-year burden. The new estimated total is 13,650 hours, an increase by 6,824 hours. There are no other changes to the collection.

---

Annual Cost to Federal Government: $525,239

Does this IC contain surveys, censuses, or employ statistical methods? Yes Part B of Supporting Statement

Does this ICR request any personally identifiable information (see OMB Circular No. A-130 for an explanation of this term)? Please consult with your agency's privacy program when making this determination.     Yes

Does this ICR include a form that requires a Privacy Act Statement (see 5 U.S.C. §552a(e)(3))? Please consult with your agency's privacy program when making this determination.     No

Is this ICR related to the Affordable Care Act [Pub. L. 111-148 & 111-152]? No

Is this ICR related to the Dodd-Frank Wall Street Reform and Consumer Protection Act, [Pub. L. 111-203]? No

Is this ICR related to the American Recovery and Reinvestment Act of 2009 (ARRA)? No

Is this ICR related to the Pandemic Response? No

---

Common Form ICR:  No

---

On behalf of this Federal agency, I certify that the collection of information encompassed by this request complies with 5 CFR 1320.9 and the related provisions of 5 CFR 1320.8(b)(3).

The following is a summary of the topics, regarding the proposed collection of information, that the certification covers:

(a) It is necessary for the proper performance of agency functions;

(b) It avoids unnecessary duplication;

(c) It reduces burden on small entities;

(d) It uses plain, coherent, and unambiguous language that is understandable to respondents;

(e) Its implementation will be consistent and compatible with current reporting and recordkeeping practices;

(f) It indicates the retention periods for recordkeeping requirements;

(g) It informs respondents of the information called for under 5 CFR 1320.8 (b)(3) about:

(i) Why the information is being collected;

(ii) Use of information;

(iii) Burden estimate;

(iv) Nature of response (voluntary, required for a benefit, or mandatory);

(v) Nature and extent of confidentiality; and

(vi) Need to display currently valid OMB control number;

(h) It was developed by an office that has planned and allocated resources for the efficient and effective management and use of the information to be collected.

(i) It uses effective and efficient statistical survey methodology (if applicable); and

(j) It makes appropriate use of information technology.

If you are unable to certify compliance with any of these provisions, identify the item by leaving the box unchecked and explain the reason in the Supporting Statement.

Certification Date: 12/14/2021

---